Story thread · 8 reports / 2 sources
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
finance.yahoo.com · 15d
First report: Alnylam Pharmaceuticals stock falls on silencer drug concerns — investing.com, 18d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.